Item 3. Legal Proceedings 19 Item 15. Exhibit and Financial Statement Schedules 26 Item 1. Business. PART I Item 2. Properties 19 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 23 Item 9B. Other Information 24 Item 11. Executive Compensation 25 Signatures 31 Part I, Item 1A of this annual report, "Risk Factors," discusses these and other important risk factors that may affect our business, results of operations and financial condition. The factors listed above a ...

CORVEL CORPORATION (Exact Name of Registrant as Specified in its Charter) Emerging growth company ☐ Item 1. Financial Statements 3 December 31, 2022 March 31, 2022 (Unaudited) Assets Current Assets Cash and cash equivalents $ 78,031,000 $ 97,504,000 Customer deposits 82,857,000 69,781,000 Accounts receivable, net 82,791,000 82,586,000 Prepaid taxes and expenses 13,064,000 15,123,000 Total current assets 256,743,000 264,994,000 Property and equipment, net 82,066,000 76,268,000 Goodwill 36,814,000 36,814,000 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to x Commission file number 0-19291 CORVEL CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 33-0282651 (State or other jurisdic ...

Financial Data and Key Metrics Changes - Revenue for the September quarter was $177 million, a 12% increase from $158 million in the same quarter of the prior year [5][23] - Earnings per share (EPS) for the quarter were $0.83, a decrease of 5.6% from $0.88 in the same quarter of the prior year [5][23] - Days sales outstanding (DSO) increased to 43 days, up three days from a year ago [27] Business Line Data and Key Metrics Changes - Revenue for patient management, including third-party administration and traditional case management, was $119 million, an annual increase of 14% [24] - Gross profit for patient management decreased by 9% due to increased staffing costs [24] - Revenue for network solutions sold in the wholesale market was $58 million, a 9% increase from the same quarter of the prior year, with gross profit up 5% [25] Market Data and Key Metrics Changes - The financial impact of musculoskeletal disorders (MSKs) in the workplace is approximately $20 billion per year, with indirect costs raising this figure to over $45 billion [11] - The company is focusing on minimizing medical spend in the musculoskeletal space through enhanced networks and service programs [13] Company Strategy and Development Direction - The company aims to differentiate its services through technological innovation and has a long-term view of success [10] - Investments in CERiS are being prioritized to enhance operational efficiencies and service outcomes [14][15] - The company is embracing a hybrid work model to improve productivity and employee morale while reducing office space by 40% by 2025 [26] Management's Comments on Operating Environment and Future Outlook - Management acknowledges challenges from the pandemic and labor market but emphasizes a strong customer retention rate of 97% [7] - The company is optimistic about future growth, particularly in the CERiS segment, and is actively investing in technology to improve service delivery [6][10] - Management believes that the current economic environment will reveal durable companies with solid foundations [9] Other Important Information - The company repurchased 164,500 shares at a total cost of $26 million during the quarter, with a total of 37.6 million shares repurchased to date [27][28] - The company received the 2022 Risk Management Team of the Year award from Business Insurance's US Insurance Awards [22] Q&A Session Summary - The Q&A session did not contain any recorded questions or answers, as the call concluded without further inquiries [28]

Financial Data and Key Metrics Changes - Revenues for the June quarter were $176 million, increasing 16% from $153 million in the same quarter of the prior year [4][23] - Earnings per share for the quarter were $0.94, a 2% increase from $0.92 per share in the same quarter of the prior year [4][23] - The company repurchased 174,822 shares at a total cost of $26.7 million during the quarter, with a total of 37.4 million shares repurchased for $681 million since inception [28] Business Line Data and Key Metrics Changes - Revenue for patient management, including TPA services, was $115 million, an annual increase of 14%, but gross profit decreased by 14% [24][25] - Revenue for network solutions sold in the wholesale market was $61 million, an increase of 18% from the same quarter of the prior year, with gross profit up 24% [26][27] Market Data and Key Metrics Changes - The company noted that inflation is at levels not experienced for many decades, impacting operational costs and the overall economic environment [9] - The workers' compensation industry is seeing higher increases in mega claims, driven by factors such as inflation, liability risk, and an aging workforce [11] Company Strategy and Development Direction - The company is focusing on automation and operational efficiencies to improve bottom line performance while managing increased operational costs [5][25] - CorVel is exploring synergistic acquisition opportunities, particularly in light of reduced valuations in the market [10] - The company continues to invest in technology and automation to enhance service delivery and operational efficiency [20][21][19] Management's Comments on Operating Environment and Future Outlook - Management expressed concerns about the ongoing economic dynamics, including inflation and the potential for a recession, which are affecting M&A activity [9] - The company remains optimistic about the demand for telehealth and virtual care models, despite regulatory challenges [15][14] Other Important Information - CorVel received the Business Insurance Innovation Award for its advanced data analytics solution, Cogency, highlighting its commitment to innovation [7][8] - The company is leveraging technology to keep injured workers engaged in their recovery, which is expected to reduce overall costs of care [16] Q&A Session Summary - The Q&A session concluded without any specific questions or answers being recorded [29]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.0001 Per Share CRVL The Nasdaq Global Select Market FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ...

CorVel Corporation (NASDAQ:CRVL) Q4 2022 Earnings Conference Call May 26, 2022 11:30 AM ET Company Participants Michael Combs - President & Chief Executive Officer Brandon O’Brien - Chief Financial Officer Conference Call Participants Operator Thank you for standing by. Welcome to the CorVel Corporation Quarterly Earnings Release Webcast. During the course of this webcast, CorVel Corporation may make projections or other forward-looking statements regarding future events or the future financial performances ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 0-19291 CorVel Corporation (Exact name of registrant as specified in its charter) Delaware 33-0282651 ( State or other jurisdiction of incor ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to x Commission file number 0-19291 CORVEL CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 33-0282651 (State or other jurisdict ...

CorVel Corporation (NASDAQ:CRVL) Q3 2022 Earnings Conference Call February 1, 2022 11:30 AM ET Company Participants Michael Combs - President and Chief Executive Officer Brandon O'Brien - Chief Financial Officer Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designe ...